MSC-derived microvesicles inhibit the progression of arthritis in a murine model of preclinical rheumatoid arthritis.
Saved in:
| Title: | MSC-derived microvesicles inhibit the progression of arthritis in a murine model of preclinical rheumatoid arthritis. |
|---|---|
| Authors: | Shixiong W; Department of Rheumatology and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China.; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.; KeyLaboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Cheng R; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Lu C; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Zhang Q; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Li SJ; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Liu ZH; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Wu Q; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Pan SY; 7Department of Rheumatology and Immunology, The Fifth People's Hospital Affiliated to Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China., Li Q; Department of Rheumatology and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Zeng XF; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China.; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.; KeyLaboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China., Liu Y; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Feb 10; Vol. 17, pp. 1723572. Date of Electronic Publication: 2026 Feb 10 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1723572 |
